Adage Capital Partners GP L.L.C. Raises Stock Holdings in Acadia Healthcare Company, Inc. $ACHC

Key Points

• Adage Capital Partners GP L.L.C. increased its stake in Acadia Healthcare by 69%, now holding approximately $13 million worth of 428,580 shares.
• Acadia Healthcare reported a 9.2% year-over-year revenue increase with earnings per share of $0.83, beating analysts' expectations.
• Wall Street analysts have a consensus rating of "Moderate Buy" for Acadia Healthcare, with an average price target of $40.77.

Adage Capital Partners GP L.L.C. lifted its holdings in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 69.0% during the 1st quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 428,580 shares of the company's stock after acquiring an additional 175,000 shares during the period. Adage Capital Partners GP L.L.C. owned 0.47% of Acadia Healthcare worth $12,995,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also made changes to their positions in ACHC. UMB Bank n.a. raised its position in shares of Acadia Healthcare by 149.5% during the 1st quarter. UMB Bank n.a. now owns 1,260 shares of the company's stock worth $38,000 after acquiring an additional 755 shares in the last quarter. Caitong International Asset Management Co. Ltd lifted its stake in Acadia Healthcare by 11,218.2% in the first quarter. Caitong International Asset Management Co. Ltd now owns 1,245 shares of the company's stock valued at $38,000 after buying an additional 1,234 shares during the last quarter. State of Wyoming purchased a new stake in Acadia Healthcare in the fourth quarter valued at approximately $56,000. Covestor Ltd lifted its stake in Acadia Healthcare by 56.0% in the first quarter. Covestor Ltd now owns 2,262 shares of the company's stock valued at $69,000 after buying an additional 812 shares during the last quarter. Finally, Twin Tree Management LP lifted its stake in Acadia Healthcare by 185.8% in the first quarter. Twin Tree Management LP now owns 5,691 shares of the company's stock valued at $173,000 after buying an additional 3,700 shares during the last quarter.

Acadia Healthcare Price Performance

ACHC traded down $0.58 during trading on Friday, reaching $21.73. 2,150,271 shares of the stock were exchanged, compared to its average volume of 2,287,824. The business's 50 day moving average price is $22.09 and its two-hundred day moving average price is $24.29. The company has a debt-to-equity ratio of 0.73, a current ratio of 1.32 and a quick ratio of 1.32. The company has a market capitalization of $2.01 billion, a price-to-earnings ratio of 14.39, a P/E/G ratio of 4.39 and a beta of 0.89. Acadia Healthcare Company, Inc. has a 1 year low of $17.13 and a 1 year high of $79.82.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last posted its earnings results on Tuesday, August 5th. The company reported $0.83 EPS for the quarter, topping analysts' consensus estimates of $0.71 by $0.12. The company had revenue of $869.23 million for the quarter, compared to the consensus estimate of $839.59 million. Acadia Healthcare had a return on equity of 8.34% and a net margin of 4.31%.Acadia Healthcare's quarterly revenue was up 9.2% compared to the same quarter last year. During the same period in the previous year, the business earned $0.91 earnings per share. Acadia Healthcare has set its FY 2025 guidance at 2.450-2.65 EPS. As a group, equities research analysts anticipate that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on ACHC shares. Royal Bank Of Canada reduced their price objective on Acadia Healthcare from $43.00 to $28.00 and set an "outperform" rating for the company in a research note on Wednesday, August 13th. Guggenheim dropped their target price on Acadia Healthcare from $36.00 to $29.00 and set a "buy" rating on the stock in a report on Thursday, August 7th. Barclays dropped their target price on Acadia Healthcare from $28.00 to $20.00 and set an "equal weight" rating on the stock in a report on Thursday, August 7th. Bank of America lowered Acadia Healthcare from a "buy" rating to a "neutral" rating and dropped their price objective for the stock from $27.00 to $25.00 in a report on Wednesday. Finally, Wall Street Zen raised Acadia Healthcare from a "sell" rating to a "hold" rating in a report on Sunday, August 3rd. Eight analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. According to MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $39.00.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.